Literature DB >> 6869119

Specific binding of [3H]mepyramine to histamine H1-receptors in vascular smooth muscle membranes.

.   

Abstract

The antagonist-sensitive binding of [3H]mepyramine to beef aortic membranes was as expected for binding to histamine H1-receptors. [3H]mepyramine binds rapidly and in saturable fashion to the specific receptor sites, specific binding reaching equilibrium in 3 min at 37 degrees C. SCATCHARD's analysis of the binding data gave a dissociation constant of 3.0 nM for the radioligand-receptor complex and maximal number of binding sites: 31 fmol/mg protein. In the competition studies histamine H1-antagonists are more potent inhibitors of radioligand binding than H2-antagonist. They inhibit [3H]mepyramine binding in the following order: mepyramine greater than triprolidine greater than promethazine much greater than cimetidine. Binding data are in correlation with the previous pharmacological studies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6869119     DOI: 10.1007/bf01967322

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  22 in total

1.  The physiological action of beta-iminazolylethylamine.

Authors:  H H Dale; P P Laidlaw
Journal:  J Physiol       Date:  1910-12-31       Impact factor: 5.182

2.  Classification and biological distribution of histamine receptor sub-types.

Authors:  N Chand; P Eyre
Journal:  Agents Actions       Date:  1975-10

3.  Pharmacologic receptor activity of rabbit aorta. Effect of dithiothreitol and N-ethylmaleimide.

Authors:  J H Fleisch; M C Krzan; E Titus
Journal:  Circ Res       Date:  1973-09       Impact factor: 17.367

4.  Alterations in pharmacologic receptor activity by dithiothreitol.

Authors:  J H Fleisch; M C Krzan; E Titus
Journal:  Am J Physiol       Date:  1974-12

5.  Characterization of [3H]mepyramine binding to the longitudinal muscle of guinea pig small intestine.

Authors:  S J Hill; J M Young
Journal:  Mol Pharmacol       Date:  1981-05       Impact factor: 4.436

6.  Solubilization of a [3H]cimetidine binding site from rat brains. A clonidine-sensitive H-2 receptor subtype?

Authors:  N Subramanian; T A Slotkin
Journal:  Mol Pharmacol       Date:  1981-09       Impact factor: 4.436

7.  Alpha adrenergic receptors in beef aortic membranes characterised by [3H] dihydroergocryptine binding.

Authors:  M Carman-Krzan
Journal:  Arch Int Pharmacodyn Ther       Date:  1980-08

8.  The binding of [3H]mepyramine to histamine H1 receptors in guinea-pig brain.

Authors:  S J Hill; P C Emson; J M Young
Journal:  J Neurochem       Date:  1978-10       Impact factor: 5.372

9.  Pharmacology of the aorta. A brief review.

Authors:  J H Fleisch
Journal:  Blood Vessels       Date:  1974

10.  Affinities of histamine H1-antagonists in guinea pig brain: similarity of values determined from [3H]mepyramine binding and from inhibition of a functional response.

Authors:  S J Hill; P Daum; J M Young
Journal:  J Neurochem       Date:  1981-11       Impact factor: 5.372

View more
  5 in total

1.  Histaminergic H1-receptors in smooth muscle and endothelium of bovine thoracic aorta.

Authors:  M Carman-Krzan
Journal:  Agents Actions       Date:  1989-04

2.  Regulation of membrane histamine H1-receptor binding sites by guanine nucleotides, mono- and divalent cations.

Authors:  M Carman-Krzan
Journal:  Agents Actions       Date:  1986-04

3.  Molecular characterization of specific H1-receptor agonists histaprodifen and its Nalpha-substituted analogues on bovine aortic H1-receptors.

Authors:  Marija Carman-Krzan; Aljosa Bavec; Matjaz Zorko; Walter Schunack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-03-25       Impact factor: 3.000

4.  Characterization of vascular histamine H1-receptors: multiple affinity states of aortic histamine H1-receptor.

Authors:  M Carman-Krzan
Journal:  Agents Actions       Date:  1985-04

5.  The effect of group selective reagents N-ethylmaleimide and dithiothreitol on histamine H1-receptor binding sites in the vascular smooth muscle membranes.

Authors:  M Carman-Krzan
Journal:  Agents Actions       Date:  1984-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.